BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10025599)

  • 1. Role of HLA in congenital heart block: susceptibility alleles in mothers.
    Sirén MK; Julkunen H; Kaaja R; Kurki P; Koskimies S
    Lupus; 1999; 8(1):52-9. PubMed ID: 10025599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Julkunen H; Siren MK; Kaaja R; Kurki P; Friman C; Koskimies S
    Br J Rheumatol; 1995 Oct; 34(10):901-7. PubMed ID: 7582692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
    Colombo G; Brucato A; Coluccio E; Compasso S; Luzzana C; Franceschini F; Quinzanini M; Scorza R
    Arthritis Rheum; 1999 Aug; 42(8):1757-64. PubMed ID: 10446878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HLA in congenital heart block: susceptibility alleles in children.
    Sirén MK; Julkunen H; Kaaja R; Ekblad H; Koskimies S
    Lupus; 1999; 8(1):60-7. PubMed ID: 10025600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence.
    Meisgen S; Östberg T; Salomonsson S; Ding B; Eliasson H; Mälarstig A; Alfredsson L; Klareskog L; Hamsten A; Olsson T; Axelsson T; ; Gadler F; Jonzon A; Sonesson SE; Kockum I; Wahren-Herlenius M
    J Intern Med; 2014 Jun; 275(6):640-51. PubMed ID: 24354957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La.
    Julkunen H; Kurki P; Kaaja R; Heikkilä R; Immonen I; Chan EK; Wallgren E; Friman C
    Arthritis Rheum; 1993 Nov; 36(11):1588-98. PubMed ID: 8240435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers.
    Miyagawa S; Shinohara K; Kidoguchi K; Fujita T; Fukumoto T; Hashimoto K; Yoshioka A; Shirai T
    Autoimmunity; 1997; 26(2):95-101. PubMed ID: 9546818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal lupus erythematosus: HLA-DR and -DQ distributions are different among the groups of anti-Ro/SSA-positive mothers with different neonatal outcomes.
    Miyagawa S; Shinohara K; Kidoguchi K; Fujita T; Fukumoto T; Yamashina Y; Hashimoto K; Yoshioka A; Sakurai S; Nishihara O; Shirai T
    J Invest Dermatol; 1997 Jun; 108(6):881-5. PubMed ID: 9182815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile.
    Meilof JF; Frohn-Mulder IM; Stewart PA; Szatmari A; Hess J; Veldhoven CH; Smeenk RJ; Swaak AJ
    Lupus; 1993 Aug; 2(4):239-46. PubMed ID: 7505695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal lupus erythematosus: analysis of HLA class II alleles in mothers and siblings from seven Japanese families.
    Miyagawa S; Shinohara K; Fujita T; Kidoguchi K; Fukumoto T; Hashimoto K; Yoshioka A; Shirai T
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):186-90. PubMed ID: 9039166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital heart block: HLA differences between affected children and healthy siblings in four Finnish families.
    Sirén MK; Julkunen H; Kaaja R; Koskimies S
    APMIS; 1997 Jun; 105(6):463-8. PubMed ID: 9236864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background.
    Brucato A; Franceschini F; Gasparini M; De Juli E; Ferraro G; Quinzanini M; Vignati G; Bortolon C; Ghessi A; Pozzoli R
    J Rheumatol; 1995 Mar; 22(3):533-40. PubMed ID: 7783076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart block immunogenetics. Evidence of an additional role of HLA class III antigens and independence of Ro autoantibodies.
    Arnaiz-Villena A; Vazquez-Rodriguez JJ; Vicario JL; Lavilla P; Pascual D; Moreno F; Martinez-Laso J
    Arthritis Rheum; 1989 Nov; 32(11):1421-6. PubMed ID: 2818659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal complete heart block with myocarditis and maternal SS-A-/AA-B/antibodies].
    Lang B; Wilhelm C; Gildein P; Vaith P; Schillinger H; Peter HH
    Schweiz Med Wochenschr; 1990 Nov; 120(46):1741-4. PubMed ID: 2251494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serologic marker for fetal risk of congenital heart block.
    Salomonsson S; Dörner T; Theander E; Bremme K; Larsson P; Wahren-Herlenius M
    Arthritis Rheum; 2002 May; 46(5):1233-41. PubMed ID: 12115229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.